Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   November 18, 2022 Policy Notices Reminder to AHRQ Grantees that FY2018 Funds will Expire on September 30, 2023 (NOT-HS-23-002) Agency for Healthcare Research and Quality AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research (NOT-HS-23-003) Agency for Healthcare Research and Quality This Notice is to expire PA-20-068 "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)" (NOT-HS-23-004) Agency for Healthcare Research and Quality General Notices Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029" (NOT-AR-23-007) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Technical Assistance Webinar for Potential Applicants to RFA-CA-23-013, Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed) (NOT-CA-23-013) National Cancer Institute Notice RFA-DK-22-010 "Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)" Is Being Reissued (NOT-DK-23-001) National Institute of Diabetes and Digestive and Kidney Diseases Notice RFA-DK-22-015 Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) is Being Reissued (NOT-DK-23-002) National Institute of Diabetes and Digestive and Kidney Diseases Notice of a Question and Answer "Office Hour" with NIGMS Staff for IMSD and G-RISE Applicants (NOT-GM-23-020) National Institute of General Medical Sciences Notice of Information on NIMH's Considerations for Research Involving Psychedelics and Related Compounds (NOT-MH-23-125) National Institute of Mental Health Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees (NOT-OD-23-019) Office of the Director, NIH Human Subjects Research: Policies, Inclusion, & Clinical Trials Free 2-Day Virtual Event with NIH & HHS Experts December 6-7, 2022 (NOT-OD-23-021) National Institutes of Health Notice of Future Research Opportunity Announcement for All of Us Research Participant and Partner Services Center (NOT-PM-23-001) Office of the Director, NIH Request for Information: Soliciting Public Comment on Draft Amyotrophic Lateral Sclerosis (ALS) Strategic Plan (NOT-NS-23-041) National Institute of Neurological Disorders and Stroke Notice of Changes to Funding Opportunities Notice of NIAMS Participation in PAR-20-089, "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)" (NOT-AR-23-010) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of NIAMS Participation in PAR-20-097, "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)" (NOT-AR-23-011) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Change to Application Due Dates and deletion of the Introduction to Application Section for RFA-DK-22-019 (NOT-DK-23-003) National Institute of Diabetes and Digestive and Kidney Diseases Notice of Early Expiration of RFA-HG-21-001, Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial Not Allowed)" & RFA-HG-21-002, Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial Not Allowed)" (NOT-HG-23-013) National Human Genome Research Institute Notice of Change in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)" (NOT-HL-22-056) National Heart, Lung, and Blood Institute Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed) (NOT-DA-22-064) National Institute on Drug Abuse National Institute of Mental Health National Institute on Minority Health and Health Disparities Office of Behavioral and Social Sciences Research Office of Research on Women's Health Notice of Intent to Publish a Funding Opportunity Announcement for Entry-Level Modules (ELM) for Training the Genomics Research Workforce (UE5-Clinical Trial Not Allowed) (NOT-HG-23-014) National Human Genome Research Institute Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) (NOT-MH-23-135) National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) (NOT-MH-23-136) National Institute of Mental Health Notices of Special Interest Notice of Special Interest (NOSI): Administrative Supplement for NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) (NOT-CA-23-012) National Cancer Institute Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment (NOT-DA-24-002) National Institute on Drug Abuse Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship (NOT-OD-23-002) Office of the Director, NIH National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Nursing Research National Library of Medicine Office of Behavioral and Social Sciences Research Office of Research on Women's Health Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-23-018) Office of the Director, NIH John E. Fogarty International Center National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research National Library of Medicine Office of Research on Women's Health Funding Opportunities Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-24-022) National Institute of Biomedical Imaging and Bioengineering National Eye Institute National Institute on Aging Application Receipt Date(s): Multiple dates, see announcement. Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) (RFA-AI-22-069) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): April 07, 2023 NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required) (RFA-CA-23-020) National Cancer Institute Application Receipt Date(s): February 28, 2023 NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required) (RFA-CA-23-021) National Cancer Institute Application Receipt Date(s): February 28, 2023 NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required) (RFA-CA-23-022) National Cancer Institute Application Receipt Date(s): February 28, 2023 HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional) (RFA-DA-23-059) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Alcohol Abuse and Alcoholism Application Receipt Date(s): February 10, 2023 HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional) (RFA-DA-23-060) National Institute on Drug Abuse National Institute on Alcohol Abuse and Alcoholism Application Receipt Date(s): February 10, 2023 Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) (RFA-DA-24-002) National Institute on Drug Abuse Application Receipt Date(s): March 23, 2023 Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed) (RFA-DK-23-002) National Institute of Diabetes and Digestive and Kidney Diseases National Heart, Lung, and Blood Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): January 12, 2023 Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) (RFA-DK-23-003) National Institute of Diabetes and Digestive and Kidney Diseases National Institute on Minority Health and Health Disparities National Institute of Nursing Research Office of Disease Prevention Application Receipt Date(s): January 12, 2023 Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) (RFA-ES-22-010) National Institute of Environmental Health Sciences Application Receipt Date(s): Multiple dates, see announcement. NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892